自身免疫性结缔组织病患者冠状动脉旁路移植术的全国性分析
该研究基于2005至2015年美国全国住院患者样本,分析接受孤立CABG的成人患者中自身免疫性结缔组织病(CTD)对结局的影响。CTD患者占1.8%,校正后CTD与死亡率无关,但心血管、神经及感染并发症风险更低,住院时间和费用更少;然而抗磷脂综合征(APLS)亚组死亡及血栓栓塞并发症风险显著增加。
要点
- CTD患者CABG后死亡率未增加,部分并发症风险反而更低。
- APLS亚组死亡及肾、感染、血栓栓塞并发症风险显著升高。
核心结论
- CTD患者接受CABG结局可接受,资源使用反而改善,但APLS患者结局较差需谨慎评估。
研究设计与样本
- 回顾性全国住院患者样本分析,2005至2015年,纳入成人孤立CABG患者,CTD队列包括类风湿关节炎、狼疮、抗磷脂综合征等。
主要发现
- 估计2,101,591例患者中41,567例(1.8%)诊断CTD,其中类风湿关节炎58%、系统性红斑狼疮12%、APLS11%。
临床怎么用
- CTD患者行CABG总体安全,但APLS患者需个体化评估手术风险与获益。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autoimmune connective tissue diseases (CTDs) are associated with accelerated atherosclerosis and inflammation, while often requiring immunosuppression. Large-scale outcomes of coronary artery bypass graft (CABG) surgery in this population have not been reported thus far. This study characterized trends in use of CABG in patients with CTDs and the impact of the disease on mortality, in-hospital complications, length of stay, and costs. METHODS: The 2005 to 2015 National Inpatient Sample was used to identify all adult patients undergoing isolated CABG. The CTDs cohort included rheumatoid arthritis, lupus erythematosus, and antiphospholipid syndrome (APLS), among others. Hierarchical multivariable logistic models were used to calculate the independent impact of CTDs on clinical outcomes and costs. RESULTS: Of an estimated 2,101,591 patients, 41,567 (1.8%) were diagnosed with CTDs (rheumatoid arthritis, 58%; systemic lupus erythematosus, 12%; APLS, 11%) Although the overall annual use of CABG decreased, the proportion of patients with CTDs receiving the operation significantly increased. After adjusting for patient and hospital characteristics, CTDs were not associated with increased mortality (adjusted odds ratio [AOR], 0.91; P = .34) but were protective against cardiovascular (AOR, 0.92; P < .003), neurologic (AOR, 0.81; P = .01), and infectious (AOR, 0.80; P = .01) complications. The diagnosis of CTDs was also predictive of reduced length of hospital stay (β-coefficient = -0.40; P < .001) and costs (β-coefficient, -$1200; P = .01). On subgroup analysis patients with APLS had significantly increased odds of mortality (AOR, 1.5) and increased renal (AOR, 1.3), infectious (AOR, 1.7), and thromboembolic (AOR, 4.3) complications (all P < .05). CONCLUSIONS: CABG in patients with CTDs provides acceptable outcomes and paradoxically improved resource use. However CABG in patients with APLS warrants careful consideration given inferior outcomes.
引用
- Aguayo E, Dobaria V, Sareh S, et al. National Analysis of Coronary Artery Bypass Grafting in Autoimmune Connective Tissue Disease. Ann Thorac Surg. 2020. PMID: 32439392. doi:10.1016/j.athoracsur.2020.03.120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。